Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PAK2 - Breast cancer cell expression profiles (G4100A)
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PAK2 - CD4+ lymphocyte polarization into Th1 and Th2 cells in the presence of TGFbeta: time course (HG-U95A)
PAK2 - Bone marrow prolonged storage effects
PAK2 - Rhabdomyosarcoma and Ewing's sarcoma comparison
PAK2 - Breast cancer and selective estrogen receptor modulators
PAK2 - Rheumatoid arthritis: synovial macrophages
PAK2 - Leukocyte inflammatory responses to lipopolysaccharide
PAK2 - Dendritic cell response to measles virus infection: time course
PAK2 - Breast cancer and docetaxel treatment
PAK2 - NCI60 cancer cell lines
GEO DataSets Gene Chromosome neighbors Homologene neighbors
PAK2 - Cyclooxygenase-2 inhibitor celecoxib effect on colorectal adenocarcinoma
PAK2 - Tamoxifen effect on endometrioid carcinomas
PAK2 - Kaposi's sarcoma-associated herpesvirus LANA overexpression in B lymphoid cells: time course
PAK2 - Chronic myelogenous leukemia response to imatinib
PAK2 - Dendritic cell response to TGF-beta1: time course
PAK2 - Interferon-alpha effect on monocytes primed with interferon-gamma
PAK2 - IFN-gamma primed macrophage response to IFN-gamma restimulation: time course
PAK2 - NF-kappaB and phosphotidylinositol 3-kinase inhibitor treated monocytes infected with the human cytomegalovirus
PAK2 - Severe combined immunodeficiency (HG-U95A)
PAK2 - Carboplatin sensitive and resistant ovarian carcinoma
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on